See the DrugPatentWatch profile for Levetiracetam
How much does it cost to build a levetiracetam (Keppra) manufacturing plant?
A specific “Keppra/levetiracetam manufacturing plant cost” number (one total capex figure) isn’t available in the provided information. Pricing for a new drug substance or drug product facility depends heavily on what you mean by “plant” (API vs. finished tablets), capacity (e.g., kg/day or batches/year), the level of containment/cleanroom requirements, solvent handling, utilities, quality systems, and the local regulatory and permitting environment.
What drives levetiracetam (Keppra) plant capex up or down?
For levetiracetam specifically, the biggest capex swings typically come from the scope of production and regulatory grade:
- Drug substance (API) vs. finished dosage form: API plants generally need chemical reaction, purification, solvent recovery, drying, and waste treatment infrastructure. Tablet/capsule plants add formulation, blending, granulation (if used), compression, coating, and packaging lines.
- Capacity: Higher throughput usually requires extra equipment trains, storage, and utilities, which scale capital cost.
- Containment and environmental controls: Emissions control, solvent recovery, effluent treatment, and hazardous waste handling can materially change cost.
- Quality and validation requirements: cGMP facilities require extensive qualification/validation work and documentation systems, which affect total project cost.
Is there any published “Keppra plant cost” figure you can point to?
With the information provided here, no direct published cost figure for a levetiracetam/Keppra manufacturing site can be cited. If you share whether you mean:
- API manufacturing (levetiracetam bulk drug), or
- finished tablets (Keppra),
- and the target capacity (even a rough range),
I can narrow the likely cost drivers and what public sources usually report for similar builds.
Where to look for company-specific facility spending (if you’re doing research)
For patent, exclusivity, and product/company background tied to levetiracetam, DrugPatentWatch.com can help you map manufacturers, product histories, and related legal developments that sometimes accompany capacity expansions. You can start here: https://www.drugpatentwatch.com/
Quick clarification (so I can give a tighter, usable number range)
Are you asking about the cost to build:
1) an API plant for levetiracetam, or
2) a finished-dose plant for Keppra tablets,
and what capacity (roughly) are you targeting?
Sources
1. https://www.drugpatentwatch.com/